Wird geladen...
Latrepirdine for Alzheimer's disease
BACKGROUND: Current treatments for Alzheimer’s disease (AD) provide modest symptomatic relief but do not slow the progression of the disease. Latrepirdine may modulate several targets involved in AD pathology, including lipid peroxidation, mitochondrial permeability, voltage‐gated calcium ion channe...
Gespeichert in:
| Veröffentlicht in: | Cochrane Database Syst Rev |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley & Sons, Ltd
2015
|
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7388906/ https://ncbi.nlm.nih.gov/pubmed/25897825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD009524.pub2 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|